Literature DB >> 7024133

Isolation of the intracellular stage of Trypanosoma cruzi and its interaction with mouse macrophages in vitro.

R M Carvalho, M N Meirelles, W de Souza, W Leon.   

Abstract

Interaction between Trypanosoma cruzi spheromastigotes (amastigotes) and mouse macrophages was studied. The spheromastigotes, isolated from the spleens of infected mice, were incorporated and digested by the macrophages. By use of horseradish peroxidase labeling of the macrophage lysosomes we showed that fusion of lysosomes with phagocytic vacuoles containing T. cruzi occurred. Parasites showing alterations indicative of digestion were seen inside the phagocytic vacuoles. Our results suggest that intracellular sphermastigotes of T. cruzi, isolated from the spleens of infected mice, and not able to induce a protective infection in mouse macrophages maintained in vitro.

Entities:  

Mesh:

Year:  1981        PMID: 7024133      PMCID: PMC350735          DOI: 10.1128/iai.33.2.546-554.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Isolation of blood and intracellular forms of Trypansoma cruzi from rats and other rodents and preliminary studies of their metabolism.

Authors:  W E Gutteridge; B Cover; M Gaborak
Journal:  Parasitology       Date:  1978-04       Impact factor: 3.234

2.  Tissue tropism of different Trypanosoma cruzi strains.

Authors:  R C Melo; Z Brener
Journal:  J Parasitol       Date:  1978-06       Impact factor: 1.276

3.  Trypanosoma cruzi: intracellular stages grown in a cell-free medium at 37 C.

Authors:  S C Pan
Journal:  Exp Parasitol       Date:  1978-08       Impact factor: 2.011

4.  Trypanosoma cruzi: in vitro interactions between cultured amastigotes and human skin-muscle cells.

Authors:  S C Pan
Journal:  Exp Parasitol       Date:  1978-08       Impact factor: 2.011

5.  Observation on the interaction of peritoneal macrophages with Trypanosoma cruzi. II. Intracellular fate of bloodstream forms.

Authors:  R Milder; J Kloetzel; M P Deane
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1977 Sep-Oct       Impact factor: 1.846

6.  Trypanosoma cruzi: infection of normal and activated mouse macrophages.

Authors:  Y Kress; H Tanowitz; B Bloom; M Wittner
Journal:  Exp Parasitol       Date:  1977-04       Impact factor: 2.011

7.  The in vitro interaction of Trypanosoma cruzi bloodstream forms and mouse peritoneal macrophages.

Authors:  A Alcantara; Z Brener
Journal:  Acta Trop       Date:  1978-09       Impact factor: 3.112

8.  Leishmania infection of human skin fibroblasts in vitro: absence of phagolysosomal fusion after induced phagocytosis of promastigotes, and their intracellular transformation.

Authors:  K P Chang
Journal:  Am J Trop Med Hyg       Date:  1978-11       Impact factor: 2.345

9.  Effect of human monocytes and macrophages on Trypanosoma cruzi.

Authors:  D M Williams; J S Remington
Journal:  Immunology       Date:  1977-01       Impact factor: 7.397

10.  Leishmania donovani. Hamster macrophage interactions in vitro: cell entry, intracellular survival, and multiplication of amastigotes.

Authors:  K P Chang; D M Dwyer
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  4 in total

1.  Mechanisms of invasion and replication of the intracellular stage in Trypanosoma cruzi.

Authors:  R E McCabe; J S Remington; F G Araujo
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

2.  Separation of amastigotes and trypomastigotes of Trypanosoma cruzi from cultured cells.

Authors:  T U de Carvalho; W de Souza
Journal:  Z Parasitenkd       Date:  1983

3.  Fibronectin increases Trypanosoma cruzi amastigote binding to and uptake by murine macrophages and human monocytes.

Authors:  E L Noisin; F Villalta
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

4.  Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells.

Authors:  V Ley; N W Andrews; E S Robbins; V Nussenzweig
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.